We are excited to join other nuclear medicine leaders from around the globe at the Annual Congress of the European Association of Nuclear Medicine in Wien, Austria.
Stop by Booth #238 or schedule a meeting with us below.
We are currently producing lutetium-177 and shipping product from our clinical-scale facility in Janesville, Wisconsin, USA. Learn more about how we're scaling our production of n.c.a. Lu-177, and about our plans for other fusion-driven medical isotopes (Mo-99,
I-131, Tb-161).
We stand apart from other fusion companies because we have commercialized fusion today and we are scaling our technology. During each of our four phases, we’re perfecting core competencies needed for commercially viable fusion, producing useful products, building shareholder value, and reinvesting in future growth.
Join us and be part of the solution.
